Vanda Pharmaceuticals Inc.
VNDA
DELAYED 1 MONTH
13 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:54 PM | Timothy WilliamsSVP & General Counsel | Sale | 42,434 | $8.27 | $350.8K | 377,450(D) | View → |
| Mar 2, 2026 | Mar 4 11:53 PM | Kevin Patrick MoranSVP, CFO & Treasurer | Sale | 42,442 | $8.27 | $350.8K | 411,380(D) | View → |
| Mar 2, 2026 | Mar 4 11:52 PM | Joakim WijkstromSVP, Chief Marketing Officer | Sale | 30,800 | $8.27 | $254.6K | 333,469(D) | View → |
| Mar 2, 2026 | Mar 4 11:51 PM | Mihael Hristos PolymeropoulosDirector, President and CEO, Other | Sale | 156,235 | $8.17 | $1.3M | 2,704,496(D) | View → |
| Mar 2, 2026 | Mar 4 11:51 PM | Gunther BirznieksSVP, Business Development | Sale | 42,431 | $8.27 | $350.7K | 494,197(D) | View → |
Stock Options & Derivatives
No transactions found.